生物股份
(600201)
| 流通市值：81.79亿 | | | 总市值：81.79亿 |
| 流通股本：11.20亿 | | | 总股本：11.20亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 970,804,600.73 | 611,731,208.51 | 347,901,401.91 | 1,598,225,460.25 |
| 营业收入 | 970,804,600.73 | 611,731,208.51 | 347,901,401.91 | 1,598,225,460.25 |
| 二、营业总成本 | 775,774,038.75 | 471,488,520.43 | 230,815,022.46 | 1,257,522,250.91 |
| 营业成本 | 425,238,182.58 | 257,398,609.38 | 136,384,204.32 | 652,246,403.19 |
| 税金及附加 | 13,409,812.39 | 10,767,291.68 | 2,756,330.52 | 23,143,682.08 |
| 销售费用 | 194,238,768.85 | 109,356,751.22 | 44,185,903.47 | 342,251,882.2 |
| 管理费用 | 92,752,560.71 | 59,904,181.66 | 30,784,503.73 | 152,559,846.13 |
| 研发费用 | 88,026,265.74 | 58,451,141.65 | 31,490,190.73 | 143,471,246.45 |
| 财务费用 | -37,891,551.52 | -24,389,455.16 | -14,786,110.31 | -56,150,809.14 |
| 其中:利息费用 | 5,126,997.83 | 4,726,553.72 | 36,521.63 | 53,397.84 |
| 其中:利息收入 | 43,121,201.51 | 29,183,607.02 | 14,860,414.67 | 56,518,105.53 |
| 加:公允价值变动收益 | 275,368.51 | 164,423.14 | 59,317 | -5,941,701.69 |
| 加:投资收益 | -6,936,195.01 | -5,229,610.34 | 23,693.02 | -1,835,709.39 |
| 资产处置收益 | 128,837.55 | 108,173.18 | 109,053.22 | -43,195.45 |
| 资产减值损失(新) | -14,663,574.21 | -8,568,920.37 | -2,982,632.4 | -35,664,785.55 |
| 信用减值损失(新) | -236,365.61 | 9,758,601.87 | 4,221,833.66 | -22,255,191.55 |
| 其他收益 | 20,266,943.73 | 10,562,402.4 | 5,086,668.13 | 40,246,828.81 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 193,865,576.94 | 147,037,757.96 | 123,604,312.08 | 315,209,454.52 |
| 加:营业外收入 | 454,389.64 | 415,889.4 | 301,626.33 | 1,202,087.41 |
| 减:营业外支出 | 733,788.88 | 393,683.51 | 341,176.27 | 580,607.42 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 193,586,177.7 | 147,059,963.85 | 123,564,762.14 | 315,830,934.51 |
| 减:所得税费用 | 23,330,156.7 | 23,450,785.6 | 17,033,418.46 | 38,733,563.99 |
| 六、净利润 | 170,256,021 | 123,609,178.25 | 106,531,343.68 | 277,097,370.52 |
| 持续经营净利润 | 170,256,021 | 123,609,178.25 | 106,531,343.68 | 277,097,370.52 |
| 归属于母公司股东的净利润 | 169,540,956.58 | 122,918,629.44 | 105,586,820.64 | 283,630,790.16 |
| 少数股东损益 | 715,064.42 | 690,548.81 | 944,523.04 | -6,533,419.64 |
| (一)基本每股收益 | 0.15 | 0.11 | 0.1 | 0.26 |
| (二)稀释每股收益 | 0.15 | 0.11 | - | - |
| 八、其他综合收益 | -7,695,409.94 | 3,746,795.87 | 3,297,272.18 | 20,857,798.88 |
| 归属于母公司股东的其他综合收益 | -7,703,240.99 | 3,751,083.92 | 3,298,462.93 | 20,868,410.29 |
| 九、综合收益总额 | 162,560,611.06 | 127,355,974.12 | 109,828,615.86 | 297,955,169.4 |
| 归属于母公司股东的综合收益总额 | 161,837,715.59 | 126,669,713.36 | 108,885,283.57 | 304,499,200.45 |
| 归属于少数股东的综合收益总额 | 722,895.47 | 686,260.76 | 943,332.29 | -6,544,031.05 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |